{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-296035","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2022-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.100566+00:00","generated_at":"2026-06-21T11:14:30.752900+00:00","sec_items":["1.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"TherapeuticsMD extends debt maturity to Dec 31, 2022; pays $4.2M accrued interest and $750K fee","bullets":["Amendment No. 17 extends Financing Agreement maturity to Dec 31, 2022, contingent on certain milestones.","Minimum cash covenant set at $7.5M; amendment fee of $750,000 paid to lenders.","Company paid approximately $4.2M in accrued and unpaid interest as of Nov 30, 2022.","Board continues evaluating options to strengthen capital structure and maintain normal operations.","Company faces going-concern risk if it cannot refinance or raise additional capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-296035","json":"https://secwatch.observer/filing/0001193125-22-296035.json","markdown":"https://secwatch.observer/filing/0001193125-22-296035.md","text":"https://secwatch.observer/filing/0001193125-22-296035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/0001193125-22-296035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/d404005d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:14:30.752900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a137afead1296d911a869a30195763b9cea3f8e8","claim":"TherapeuticsMD, Inc. amended Amendment No. 17 with Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”) valued at amendment fee in the amount of $750,000 (effective 2022-11-30).","evidence_excerpt":"On November 30, 2022 (the “Amendment Date”), TherapeuticsMD, Inc., a Nevada corporation (the “Company”), entered into Amendment No. 17 (“Amendment No. 17”) to that certain Financing Agreement, dated as of April 24, 2019, as amended, with Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”), and certain of the Company’s subsidiaries party thereto from time to time as guarantors (the “Financing Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/0001193125-22-296035-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”)"},{"label":"Value","value":"amendment fee in the amount of $750,000"},{"label":"Effective","value":"2022-11-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}